How are NKTR covered call max profit and max loss calculated?

Max profit equals short-strike minus cost basis plus premium times 100; max loss is cost basis minus premium (at zero). Breakeven is cost basis minus premium. For the NKTR covered call priced from the end-of-day chain at a 30-day expiry (ATM IV 66.20%), the computed maximum profit is $609.50 per contract and the computed maximum loss is -$6,389.50 per contract. Live intraday quotes will differ as the chain moves through the trading session.

What is the breakeven for a NKTR covered call?

The breakeven for the NKTR covered call priced on this page is roughly $63.91 at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current NKTR market-implied 1-standard-deviation expected move is approximately 18.98%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.

How does current NKTR implied volatility affect this covered call?

NKTR ATM IV is at 66.20% with IV rank near 13.08%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.

NKTR Covered Call Strategy

NKTR (Nektar Therapeutics), in the Healthcare sector, (Biotechnology industry), listed on NASDAQ.

Nektar Therapeutics is a biopharmaceutical firm dedicated to the global discovery and advancement of therapies addressing significant unmet medical requirements. Central to its robust pipeline is Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist. This drug is currently in Phase 3 clinical trials for metastatic melanoma, renal cell carcinoma, muscle-invasive bladder cancer, head and neck squamous cell carcinoma, and adjuvant melanoma. It is also being evaluated in Phase 2 for renal cell carcinoma, non-small cell lung cancer, and urothelial cancer; Phase 1/2A for head and neck squamous cell carcinoma; Phase 1/2 for various solid tumors; and Phase 1B for COVID-19. Additionally, Nektar is developing NKTR-358, a cytokine Treg stimulant, which is in Phase 2 trials for systemic lupus erythematosus and ulcerative colitis, and Phase 1B for atopic dermatitis and psoriasis. Their portfolio further includes NKTR-255, an IL-15 receptor agonist, undergoing Phase 1/2 trials for non-Hodgkin's lymphoma, multiple myeloma, head and neck cancer, and colorectal cancer.

NKTR (Nektar Therapeutics) trades in the Healthcare sector, specifically Biotechnology, with a market capitalization of approximately $1.24B, a beta of 1.15 versus the broader market, a 52-week range of 21.02-109, average daily share volume of 1.1M, a public-listing history dating back to 1994, approximately 61 full-time employees. These structural characteristics shape how NKTR stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.

A beta of 1.15 places NKTR roughly in line with broader market moves, so the strategy payoff and realized volatility track the index-equivalent baseline.

What is a covered call on NKTR?

A covered call pairs long stock with a short out-of-the-money call, collecting premium and capping upside above the short strike in exchange for income.

Current NKTR snapshot

As of June 29, 2026, spot at $66.33, ATM IV 66.20%, IV rank 13.08%, expected move 18.98%. The covered call on NKTR below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 18-day expiry.

Why this covered call structure on NKTR specifically: NKTR IV at 66.20% is on the cheap side of its 1-year range, which means a premium-selling NKTR covered call collects less credit per unit of strike-width risk, with a market-implied 1-standard-deviation move of approximately 18.98% (roughly $12.59 on the underlying). The 18-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated NKTR expiries trade a higher absolute premium for lower per-day decay. Position sizing on NKTR should anchor to the underlying notional of $66.33 per share and to the trader's directional view on NKTR stock.

NKTR covered call setup

The NKTR covered call below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With NKTR near $66.33, the first option leg uses a $70.00 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed NKTR chain at a 18-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 NKTR shares for the stock leg in covered calls and collars).

Action	Type	Strike / Basis	Premium (est)
Buy 100 shares	Stock	$66.33	long
Sell 1	Call	$70.00	$2.43

NKTR covered call risk and reward

Net Premium / Debit: -$6,390.50
Max Profit (per contract): $609.50
Max Loss (per contract): -$6,389.50
Breakeven(s): $63.91
Risk / Reward Ratio: 0.095

Max profit equals short-strike minus cost basis plus premium times 100; max loss is cost basis minus premium (at zero). Breakeven is cost basis minus premium.

NKTR covered call payoff curve

Modeled P&L at expiration across a range of underlying prices for the covered call on NKTR. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.

P&L at expiration across the modeled underlying-price range. Green shading marks profitable regions, red shading marks loss regions. Dotted purple verticals mark breakevens; the solid dark vertical marks current spot.

Underlying Price	% From Spot	P&L at Expiration
$0.01	-100.0%	-$6,389.50
$14.67	-77.9%	-$4,923.02
$29.34	-55.8%	-$3,456.54
$44.00	-33.7%	-$1,990.05
$58.67	-11.5%	-$523.57
$73.33	+10.6%	+$609.50
$88.00	+32.7%	+$609.50
$102.66	+54.8%	+$609.50
$117.33	+76.9%	+$609.50
$131.99	+99.0%	+$609.50

When traders use covered call on NKTR

Covered calls on NKTR are an income strategy run on existing NKTR stock positions; traders typically sell calls at 25-35 delta with 30-45 days to expiration to balance premium against upside cap.

NKTR thesis for this covered call

The market-implied 1-standard-deviation range for NKTR extends from approximately $53.74 on the downside to $78.92 on the upside. A NKTR covered call collects premium on an existing long NKTR position, trading off upside above the short call strike for immediate income; the short strike selection should reflect the trader's view on whether NKTR will breach that level within the expiration window. Current NKTR IV rank near 13.08% sits in the lower third of its 1-year distribution, where IV often re-expands toward the mean; this favors premium-buying structures and disadvantages premium-selling structures on NKTR at 66.20%. As a Healthcare name, NKTR options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to NKTR-specific events.

NKTR covered call positions are structurally neutral to slightly bullish; the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. NKTR positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move NKTR alongside the broader basket even when NKTR-specific fundamentals are unchanged. Short-premium structures like a covered call on NKTR carry tail risk when realized volatility exceeds the implied move; review historical NKTR earnings reactions and macro stress periods before sizing. Always rebuild the position from current NKTR chain quotes before placing a trade.

Frequently asked questions

What is a covered call on NKTR?: A covered call on NKTR is the covered call strategy applied to NKTR (stock). The strategy is structurally neutral to slightly bullish: A covered call pairs long stock with a short out-of-the-money call, collecting premium and capping upside above the short strike in exchange for income. With NKTR stock trading near $66.33, the strikes shown on this page are snapped to the nearest listed NKTR chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
How are NKTR covered call max profit and max loss calculated?: Max profit equals short-strike minus cost basis plus premium times 100; max loss is cost basis minus premium (at zero). Breakeven is cost basis minus premium. For the NKTR covered call priced from the end-of-day chain at a 30-day expiry (ATM IV 66.20%), the computed maximum profit is $609.50 per contract and the computed maximum loss is -$6,389.50 per contract. Live intraday quotes will differ as the chain moves through the trading session.
What is the breakeven for a NKTR covered call?: The breakeven for the NKTR covered call priced on this page is roughly $63.91 at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current NKTR market-implied 1-standard-deviation expected move is approximately 18.98%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
When should you consider a covered call on NKTR?: Covered calls on NKTR are an income strategy run on existing NKTR stock positions; traders typically sell calls at 25-35 delta with 30-45 days to expiration to balance premium against upside cap.
How does current NKTR implied volatility affect this covered call?: NKTR ATM IV is at 66.20% with IV rank near 13.08%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.